In individuals with Fish Eye Disease, mutations in the LCAT gene lead to reduced or absent enzyme activity. This impairment disrupts the catalytic conversion of free cholesterol, leading to an accumulation of unesterified cholesterol in the blood. Over time, this can result in the formation of cloudy deposits in the eyes, giving the disease its name, as well as other systemic effects.
